centerwatch-logo-text WEBINAR


Improving Diversity and Inclusion in Clinical Trials

A Free CenterWatch Webinar


Tuesday, Oct. 27, 2020  |  1:30 p.m. - 3:00 p.m. EDT
Location: Your office or conference room (no need to travel!)


The lack of diversity in clinical trials has been a historical concern and the global COVID-19 pandemic has brought these issues, once again, to the forefront of the industry’s mind.

In this timely free webinar — hosted by Lori Abrams, Executive Director of Patient Advocacy and Diversity at WCG — we’ll discuss the increasing attention on the underrepresentation of minority participants in clinical trials and the disproportionately severe impact of COVID-19 on these communities. On top of the overarching need for better inclusion, greater minority participation in clinical trials will help ensure that any vaccine developed to solve the current health crisis is safe and effective.

Ken Getz — Deputy Director and Research Professor at Tufts Center for the Study of Drug Development (CSDD) — will moderate a conversation with Zak Smith — Senior Research Analyst at Tufts CSDD — and Jasmine Benger — Associate Director of Research Services at CISCRP — about this deficit of diversity in clinical trials and ways in which progress can be made to grow inclusiveness. They’ll share practical tips for reaching and connecting with minority communities as trial participants and reveal details from their own related studies.

During this free webinar, we will cover:

  • The Current State of Diversity in FDA-Regulated Drug Approvals
    1. Quantitative data around diversity in clinical trials
    2. The magnitude of underrepresentation in pivotal trials

  • Improving Inclusion
    1. Steps toward better outreach to minority and disadvantaged communities
    2. Working with local organizations and disease associations to increase minority participation
    3. Achieving greater clinical research literacy and understanding within minority communities
    4. Honing communication skills around the nature of clinical studies
    5. Debunking myths and attitudes about clinical research among minority communities to better enable participation

  • Practical Strategies for Addressing Diversity and Inclusion
    1. Encouragement from trusted physicians
    2. Strengthening trust in the healthcare system
    3. Supervision by a culturally similar trial coordinator or principal investigator
    4. Clinical trial brochures that provide details about studies in a language appropriate to the community
    5. Community vetted researchers conducting studies

Clinical trials will never be as safe and effective as they can be until researchers include minority communities in a substantial and significant way. Dig into the current state of diversity in studies and learn ways to improve inclusion in your practice.

Join us by registering for this free webinar today.

Who Will Benefit:

  • Research sponsors
  • CROs
  • Clinical teams
  • Clinical operations professionals
  • Patient recruitment professionals
  • Diversity champions
  • Trial design professionals
  • GCP professionals
Meet Your Host, Moderator and Presenters:



Lori Abrams
Executive Director of Patient Advocacy and Diversity

Lori Abrams, Executive Director of Patient Advocacy and Diversity at WCG, has a long history of improving clinical drug development by including patients, caregivers and advocacy groups into every aspect of the development continuum. In her last corporate role, Lori was the Director of Diversity and Patient Engagement in Research and Development at Bristol-Myers Squibb (BMS). She built one of the first clinical trial advocacy groups in pharma. It focused on bringing awareness, accessibility and the voice of the patient to clinical trials across multiple therapeutic areas. Her team concentrated on health disparities and identified strategies for building relationships with minority communities by fostering partnerships with members of medical, faith based, community and political groups.


Ken Getz

Deputy Director and Research Professor
Tufts Center for the Study of Drug Development (CSDD)

Ken Getz, Deputy Director and Research Professor of the Tufts Center for the Study of Drug Development (CSDD), is an internationally recognized expert in research and development, clinical trial management practices and trends, the global investigative site landscape, site management, patient recruitment and retention practices and the worldwide market for outsourcing clinical research functions. His research studies on protocol design complexity and clinical research efficiency and effectiveness were conducted over the past two decades and are considered by many in the research-based life sciences industry to be pioneering work. His over 20 years of original research benchmarking R&D management practices, global outsourcing and the investigative site landscape have contributed to the industry-wide understanding of these critical markets and improvements in management strategy and execution.


Zak Smith

Senior Research Analyst
Tufts CSDD

Zak Smith, a Senior Research Analyst at Tufts CSDD, is will share the results of a new study quantifying the magnitude of underrepresentation by demographic subgroup in pivotal trials supporting drug approvals.


Jasmine Benger

Associate Director of Research Services

Jasmine Benger, an Associate Director of Research Services at CISCRP, will present the results of a global study looking at minority community attitudes and perceptions about clinical trials.